Clinical Trial Management System Market (Enterprise Clinical Trial Management System & Site Clinical Trial Management System; Web Based, Licensed Enterprise, Cloud Based; Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations, Medical Device Companies; North America, Europe, Asia-Pacific) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

September 2017 | 115 pages | ID: C3B0723CE14EN
Variant Market Research

Abstracts

Global Clinical Trial Management System Market is estimated to reach $3,407 million by 2024; growing at a CAGR of 13.7% from 2016 to 2024. Clinical trial management system (CTMS) is a software system majorly used by pharmaceutical and biotechnological sector for managing the clinical trials data that are generated during clinical research. These software aids in maintaining and managing the report, recruitments, data collection & storage, planning, tracking milestones and deadlines. Development of advanced CTMS have led to reduced communication period along with ability to access the data irrespective of time and place. Furthermore, these software systems can also be customized according to the need of customers, which will also aid in reducing time and cost and enable fast process of drug development.

The global clinical trial management system market is driven by factors including growing number of clinical trials, rising R&D budgets, increasing product launches, and accuracy of data provided. However, lack of skill professionals, limited budgets, and stringent regulations may pose several restrictions for the development of the market. Additionally, market expansion would provide future scope for competitors.

The global clinical trial management system market is categorized into type, component, mode of delivery, end-user, and geography. The market is segmented on basis of type as enterprise clinical trial management system and site clinical trial management system. The clinical trial management system market is bifurcated into component as software and services. On basis of mode of delivery, the market is segmented into licensed enterprise (on-premise), web based (on-demand), and cloud based (SaaS) segments. Furthermore, and end-user market is segmented as contract research organizations, pharmaceutical and biopharmaceutical companies, medical device companies, and others.

Based on geography, global clinical trial management system market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is further bifurcated as U.S., Canada, and Mexico whereas Europe segment consist of UK, Germany, France, Italy, and others. Asia-Pacific is segmented into India, China, Japan, South Korea, and others while RoW is bifurcated into South America, Middle East, and Africa.

The key market players include Mednet Solutions, Oracle Corporation, Guger Technologies Inc., BioOptronics Inc., Medidata Solutions Inc, Bioclinica, Forte Research Systems, Parexel International Corporation, DATATRAK International, Inc., and ICON plc, among others.

THE KEY TAKEAWAYS FROM THE REPORT

• The report will provide detailed analysis of the Global Clinical Trail Management System Market with respect to major segments such as type, component, mode of delivery, and end-user
• The report will include the qualitative and quantitative analysis with market estimation over 2015-2024 and compound annual growth rate (CAGR) between 2016 and 2024
• Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report
• An exhaustive regional analysis of Global Clinical Trial Management System Market has been included in the report
• Profile of the key players in the Global Clinical Trial Management System Market will be provided, which include key financials, product & services, new developments and business strategies

SCOPE OF CLINICAL TRAIL MANAGEMENT SYSTEM MARKET

Type Segments

• Enterprise Clinical Trial Management System
• Site Clinical Trial Management System

Component Segments

• Software
• Services

Mode of delivery Segments

• Licensed Enterprise (On-Premise)
• Web Based (On-Demand)
• Cloud Based (SaaS)

End-User Segments

• Contract Research Organizations
• Pharmaceutical and Biopharmaceutical Companies
• Medical Device Companies
• Other End Users

Geographical Segments

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Others
• Asia-Pacific
• India
• China
• Japan
• South Korea
• Others
• RoW
• South America
• Middle East
• Africa

Contents

CHAPTER 1 PREFIX

1.1 Market Scope
1.2 Report Description
1.3 Research Methodology
  1.3.1 Primary Research
  1.3.2 Secondary Research
  1.3.3 In-house Data Modeling

CHAPTER 2 EXECUTIVE SUMMARY


CHAPTER 3 MARKET OUTLINE

3.1 Market Inclination, Trend, Outlook and Viewpoint
3.2 Market Share Analysis: Company’s Competitive Scenario
3.3 Market Dynamics
  3.3.1 Drivers
    3.3.1.1 Impact Analysis
  3.3.2 Restraints
    3.3.2.1 Impact Analysis
  3.3.3 Opportunities

CHAPTER 4 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET BY COMPONENT: MARKET SIZE AND FORECAST, 2015 – 2024

4.1 Overview
4.2 Software
  4.2.1 Current Trend and Analysis
  4.2.2 Market Size and Forecast
4.3 Services
  4.3.1 Current Trend and Analysis
  4.3.2 Market Size and Forecast

CHAPTER 5 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET BY TYPE: MARKET SIZE AND FORECAST, 2015 – 2024

5.1 Overview
5.2 Enterprise Clinical Trial Management System
  5.2.1 Current Trend and Analysis
  5.2.2 Market Size and Forecast
5.3 Site Clinical Trial Management System
  5.3.1 Current Trend and Analysis
  5.3.2 Market Size and Forecast

CHAPTER 6 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET BY MODE OF DELIVERY: MARKET SIZE AND FORECAST, 2015 – 2024

6.1 Overview
6.2 Web Based (On-Demand)
  6.2.1 Current Trend and Analysis
  6.2.2 Market Size and Forecast
6.3 Licensed Enterprise (On-Premise)
  6.3.1 Current Trend and Analysis
  6.3.2 Market Size and Forecast
6.4 Cloud Based (SaaS)
  6.4.1 Current Trend and Analysis
  6.4.2 Market Size and Forecast

CHAPTER 7 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET BY END-USER: MARKET SIZE AND FORECAST, 2015 – 2024

7.1 Overview
7.2 Pharmaceutical and Biopharmaceutical Companies
  7.2.1 Current Trend and Analysis
  7.2.2 Market Size and Forecast
7.3 Contract Research Organizations
  7.3.1 Current Trend and Analysis
  7.3.2 Market Size and Forecast
7.4 Medical Device Companies
  7.4.1 Current Trend and Analysis
  7.4.2 Market Size and Forecast
7.5 Other End Users
  7.5.1 Current Trend and Analysis
  7.5.2 Market Size and Forecast

CHAPTER 8 CLINICAL TRIAL MANAGEMENT SYSTEM MARKET BY GEOGRAPHY: MARKET SIZE AND FORECAST, 2015 – 2024

8.1 Overview
8.2 North America
  8.2.1 Current Trend and Analysis
  8.2.2 Market Size and Forecast
  8.2.3 US
    8.2.3.1 Market Size and Forecast
  8.2.4 Canada
    8.2.4.1 Market Size and Forecast
  8.2.5 Mexico
    8.2.5.1 Market Size and Forecast
8.3 Europe
  8.3.1 Current Trend and Analysis
  8.3.2 Market Size and Forecast
  8.3.3 Germany
    8.3.3.1 Market Size and Forecast
  8.3.4 France
    8.3.4.1 Market Size and Forecast
  8.3.5 United Kingdom
    8.3.5.1 Market Size and Forecast
  8.3.6 Italy
    8.3.6.1 Market Size and Forecast
  8.3.7 Others
    8.3.7.1 Market Size and Forecast
8.4 Asia-Pacific
  8.4.1 Current Trend and Analysis
  8.4.2 Market Size and Forecast
  8.4.3 China
    8.4.3.1 Market Size and Forecast
  8.4.4 India
    8.4.4.1 Market Size and Forecast
  8.4.5 Japan
    8.4.5.1 Market Size and Forecast
  8.4.6 South Korea
    7.4.6.1 Market Size and Forecast
  8.4.7 Others
    8.4.7.1 Market Size and Forecast
8.5 RoW
  8.5.1 Current Trend and Analysis
  8.5.2 Market Size and Forecast
  8.5.3 Middle East
    8.5.3.1 Market Size and Forecast
  8.5.4 South America
    8.5.4.1 Market Size and Forecast
  8.5.5 Africa
    8.5.5.1 Market Size and Forecast

CHAPTER 9 COMPANY PROFILES

9.1 Oracle Corporation
9.2 Medidata Solutions Inc
9.3 Parexel International Corporation
9.4 Mednet Solutions
9.5 Bioclinica
9.6 BioOptronics, Inc.
9.7 DATATRAK International, Inc.
9.8 Guger Technologies Inc.
9.9 Forte Research Systems
9.10 ICON plc